Please login to the form below

Not currently logged in
Email:
Password:

AZ announces further job cuts

Anglo-Swedish pharma company AstraZeneca (AZ) is planning on cutting a further 4,300 jobs by 2010 in order to cut costs as it aims to make annual savings of USD900m (GBP440m).

Anglo-Swedish pharma company AstraZeneca (AZ) is planning on cutting a further 4,300 jobs by 2010 in order to cut costs as it aims to make annual savings of USD900m (GBP440m).

The company announced 3,000 job cuts in February, and another 300 marketing job cuts in May.

Around 1,800 jobs will go in European sales and marketing, another 1,800 to go in business infrastructure, and 700 roles to go in R&D.

Total restructuring costs are expected to amount to USD1.6bn.

The firm has suffered several high profile late-stage drug failures in the last year, with a stroke treatment failing in trials in January, heart drug AGI-1067 failing in March, and news that results for its blockbuster Crestor have been mixed.

27th July 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

David Atkins
A snapshot of Congenica
PME talks to CEO David Atkins...
Data desires
What are you looking to achieve with data and how are you preparing yourself to react to the results?...
The balancing act that’s keeping pharma and biotech market access on its toes
Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to...

Infographics